These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16595706)

  • 41. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
    Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
    Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure of the homodimeric androgen receptor ligand-binding domain.
    Nadal M; Prekovic S; Gallastegui N; Helsen C; Abella M; Zielinska K; Gay M; Vilaseca M; Taulès M; Houtsmuller AB; van Royen ME; Claessens F; Fuentes-Prior P; Estébanez-Perpiñá E
    Nat Commun; 2017 Feb; 8():14388. PubMed ID: 28165461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J; Mongan NP; Harland S; Hughes IA
    Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.
    Sack JS; Kish KF; Wang C; Attar RM; Kiefer SE; An Y; Wu GY; Scheffler JE; Salvati ME; Krystek SR; Weinmann R; Einspahr HM
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4904-9. PubMed ID: 11320241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain.
    van de Wijngaart DJ; van Royen ME; Hersmus R; Pike AC; Houtsmuller AB; Jenster G; Trapman J; Dubbink HJ
    J Biol Chem; 2006 Jul; 281(28):19407-16. PubMed ID: 16690616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.
    Bai S; He B; Wilson EM
    Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A partially open conformation of an androgen receptor ligand-binding domain with drug-resistance mutations.
    Doamekpor SK; Peng P; Xu R; Ma L; Tong Y; Tong L
    Acta Crystallogr F Struct Biol Commun; 2023 Apr; 79(Pt 4):95-104. PubMed ID: 36995121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.
    Lagarde WH; Blackwelder AJ; Minges JT; Hnat AT; French FS; Wilson EM
    J Biol Chem; 2012 Mar; 287(14):10905-15. PubMed ID: 22334658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer.
    Matias PM; Carrondo MA; Coelho R; Thomaz M; Zhao XY; Wegg A; Crusius K; Egner U; Donner P
    J Med Chem; 2002 Mar; 45(7):1439-46. PubMed ID: 11906285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Learning from estrogen receptor antagonism: structure-based identification of novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.
    Liu B; Geng G; Lin R; Ren C; Wu JH
    Chem Biol Drug Des; 2012 Mar; 79(3):300-12. PubMed ID: 22151347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
    Jehle K; Cato L; Neeb A; Muhle-Goll C; Jung N; Smith EW; Buzon V; Carbó LR; Estébanez-Perpiñá E; Schmitz K; Fruk L; Luy B; Chen Y; Cox MB; Bräse S; Brown M; Cato AC
    J Biol Chem; 2014 Mar; 289(13):8839-51. PubMed ID: 24523409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor.
    Steketee K; Berrevoets CA; Dubbink HJ; Doesburg P; Hersmus R; Brinkmann AO; Trapman J
    Eur J Biochem; 2002 Dec; 269(23):5780-91. PubMed ID: 12444966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain.
    Uo T; Dvinge H; Sprenger CC; Bradley RK; Nelson PS; Plymate SR
    Oncogene; 2017 Mar; 36(10):1440-1450. PubMed ID: 27694897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
    He B; Kemppainen JA; Wilson EM
    J Biol Chem; 2000 Jul; 275(30):22986-94. PubMed ID: 10816582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor.
    Liu Q; Su S; Blackwelder AJ; Minges JT; Wilson EM
    J Biol Chem; 2011 Aug; 286(34):29951-63. PubMed ID: 21730049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment.
    Thin TH; Wang L; Kim E; Collins LL; Basavappa R; Chang C
    J Biol Chem; 2003 Feb; 278(9):7699-708. PubMed ID: 12499384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.
    Wu JH; Gottlieb B; Batist G; Sulea T; Purisima EO; Beitel LK; Trifiro M
    Hum Mutat; 2003 Dec; 22(6):465-75. PubMed ID: 14635106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the androgenicity of ligands using a single-chain probe carrying androgen receptor N-terminal peptides.
    Kim SB; Umezawa Y; Tao H
    Anal Sci; 2009 Dec; 25(12):1415-20. PubMed ID: 20009327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.